Clinical Research Directory
Browse clinical research sites, groups, and studies.
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
Sponsor: First Affiliated Hospital of Zhejiang University
Summary
The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with neuroblastoma.
Official title: Prospective Clinical Study of 18F-mFBG PET Imaging in Neuroblastoma
Key Details
Gender
All
Age Range
Any - 18 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-02-04
Completion Date
2029-12
Last Updated
2025-08-08
Healthy Volunteers
No
Conditions
Interventions
18F-MFBG
Patients with neuroblastoma malignancies receive 5.55 MBq/kg of 18F-MFBG intravenously followed by PET/CT or PET/MR after 60min of injection.
Locations (1)
The First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China